Insider Transactions in Q3 2025 at Natera, Inc. (NTRA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 20
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,522
+2.07%
|
-
|
|
Jul 20
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+1.88%
|
-
|
|
Jul 20
2025
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
190
+0.08%
|
-
|
|
Jul 20
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+0.42%
|
-
|
|
Jul 16
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-1.23%
|
$457,430
$149.96 P/Share
|
|
Jul 02
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
3,000
-1.35%
|
$480,000
$160.18 P/Share
|
|
Jul 01
2025
|
Gail Boxer Marcus |
SELL
Open market or private sale
|
Direct |
4,299
-18.94%
|
$717,933
$167.31 P/Share
|
|
Jul 01
2025
|
Gail Boxer Marcus |
BUY
Exercise of conversion of derivative security
|
Direct |
4,299
+25.72%
|
$103,176
$24.42 P/Share
|
|
Jul 01
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,000
-0.57%
|
$498,000
$166.23 P/Share
|
|
Jul 01
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
2,156
-0.41%
|
$355,740
$165.87 P/Share
|
|
Jul 01
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
3,187
-1.79%
|
$532,229
$167.19 P/Share
|